Evidence map›Paper›PMID 42440768›Full record

ArticleERJ open research2026

ERS Congress 2025: highlights from the Interstitial Lung Diseases Assembly.

Johad Khoury, Aycan Yüksel, Nikoleta Bizymi, Antonio Fabozzi, Marta Garcia-Moyano, Marlies Wijsenbeek, Michael Kreuter, Laura Fabbri

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Johad KhouryPulmonary, Critical Care and Sleep Medicine, Yale University, New Haven, CT, USA.ORCID https://orcid.org/0000-0001-8048-1542
Aycan YükselDepartment of Respiratory Medicine, TOBB Economics and Technology University, Ankara, Turkey.ORCID https://orcid.org/0000-0003-0183-6232
Nikoleta BizymiLaboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece.ORCID https://orcid.org/0000-0001-5199-1519
Antonio FabozziDepartment of Public Health and Infectious Diseases, Pulmonology Unit, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
Marta Garcia-MoyanoUnit for Interstitial Lung Diseases, Department of Respiratory Medicine, Cruces University Hospital, Barakaldo, Spain.
Marlies WijsenbeekCentre of Interstitial Lung Diseases, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
Michael KreuterMainz Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany.
Laura FabbriNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-8250-6464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42440768
PMCPMC13334353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.